Evidence map›Paper›PMID 40496865›Full record

ArticleFrontiers in immunology2025

The HL-60 clone 15 cell line as a model for leukocyte migration-possibilities and limitations.

Lena Griesbaum, Christopher Weusthof, Thorben Sauer, Timo Gemoll, Gregor Weirich, Ludger Klimek, Julie Petry, Ali Bashiri Dezfouli, Maria Shoykhet, Barbara Wollenberg

Abstract read
In one paragraph

Article in Frontiers in immunology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Lena GriesbaumDepartment of Otolaryngology, Head and Neck Surgery, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
Christopher WeusthofDepartment of Otolaryngology, Head and Neck Surgery, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
Thorben SauerSection for Translational Surgical Oncology & Biobanking, Department of Surgery, University Hospital Schleswig- Holstein and University of Lübeck, Lübeck, Germany.
Timo GemollSection for Translational Surgical Oncology & Biobanking, Department of Surgery, University Hospital Schleswig- Holstein and University of Lübeck, Lübeck, Germany.
Gregor WeirichInstitute of Pathology, Section for Cytology, Technical University of Munich, School of Medicine and Health, Munich, Germany.
Ludger KlimekDepartment of Otolaryngology, Head and Neck Surgery, University Medical Centre Mainz, Mainz, Germany.
Julie PetryDepartment of Otolaryngology, Head and Neck Surgery, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
Ali Bashiri DezfouliDepartment of Otolaryngology, Head and Neck Surgery, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
Maria ShoykhetDepartment of Otolaryngology, Head and Neck Surgery, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.
Barbara WollenbergDepartment of Otolaryngology, Head and Neck Surgery, Technical University of Munich, School of Medicine and Health, TUM University Hospital, Munich, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: As a part of the innate immune system, eosinophils are recruited during infectious diseases, to release their characteristic cytotoxic granules and catch pathogens in extracellular traps. Moreover, eosinophils have a crucial role in autoimmune diseases, for example allergies. The isolation of these densest and lowest abundant leukocytes is cost-and labor intense. This sets restrictions on many aspects of eosinophilic research. In this study, we performed a thorough characterization and functional assessment of the HL-60 clone 15 (HC15) cell line, which can be differentiated into eosinophil-like cells, to investigate its potential in eosinophil research. Methods: HC15 cells were differentiated with sodium butyrate with or without IL-5 and cells were characterized and compared to primary eosinophils, neutrophils and peripheral blood mononuclear cells. Cell features were analyzed using proteomics, morphologic assessment, RT-qPCR, immunofluorescent staining and flow cytometry. Based on these results, functional tests were performed, including transwell migration assays, flow cytometry-based aggregate formation assays, immunofluorescent microscopy-based adherence assays to endothelial cells and flow cytometry- and ELISA-based activation assays. Results: The proteomes of the cell line cells differed from those of primary eosinophils and neutrophils. Differentiation of HC15 cells enhanced the expression of GATA-1 and altered the expression of surface markers IL-5R, EMR1, and TREM-1. Differentiated HC15 cells overexpressed the granule protein EPX compared to primary eosinophils and induced a distinct inflammatory milieu by secreting CCL-5, EPX and IL-8. The addition of IL-5 during differentiation increased this effect. Cell line cells responded weaker to activation than primary eosinophils but showed a similar migration and adherence pattern in multiple assays. These features were mostly unaffected by differentiation. Discussion: Differentiation of HC15 cells induces an eosinophil lineage-committed precursor state. Hence, the differentiated cell line cells lacked characteristic features of eosinophils such as morphologic attributes, surface marker expression and the capacity to be activated. However, the cells were able to migrate, form aggregates with platelets and similarly adhere to endothelial cells as primary eosinophils. It is, therefore, advisable to use the cell line as an eosinophilic model only in research questions related to chemotaxis and migration.

Indexed as

Cell MovementEosinophilsCell DifferentiationHL-60 CellsHumansNeutrophilsallergychemotaxiseosinophil biologyeosinophilic differentiationeosinophilic researchimmunologymigrationproteomics

Identifiers

PMID40496865
PMCPMC12148902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.